- cELISA
Supplier Data
Competitive ELISA - 8-iso-PGF2alpha ELISA Kit (AB133043)
Typical Standard Curve - Overnight Format.
Representative Standard Curve using ab133043. Overnight Format.
- cELISA
Supplier Data
Competitive ELISA - 8-iso-PGF2alpha ELISA Kit (AB133043)
Typical Standard Curve - 2 Hour Format.
Representative Standard Curve using ab133043. 2 Hour Format.
Reactivity data
Product details
Abcam's Direct 8-iso-PGF2alpha in vitro competitive ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate quantitative measurement of 8-iso-PGF2α in Biological fluids.
A goat anti-rabbit IgG antibody has been precoated onto 96-well plates. Standards or test samples are added to the wells, along with an alkaline phosphatase (AP) conjugated-8-iso-PGF2alpha antigen and a rabbit polyclonal antibody specific to 8-iso-PGF2alpha. After incubation the excess reagents are washed away. pNpp substrate is added and after a short incubation the enzyme reaction is stopped and the yellow color generated is read at 405 nm. The intensity of the yellow coloration is inversely proportional to the amount of 8-iso-PGF2alpha captured in the plate.
The 8-epimer of Prostaglandin F2α (8-iso-PGF2α) is produced in vivo by both non-cyclooxygenase and cyclooxygenase dependent mechanisms from arachidonic acid. 8-iso-PGF2α has been shown to be a potent vasoconstrictor, a potential mediator of hepatorenal syndrome and atherosclerosis and a mutagen in 3T3 cells and in vascular smooth muscle cells. It has also been postulated to participate as a pathophysiological mediator and is able to modify the fluidity and integrity of membranes. 8-isoPGF2α has been shown to circulate in plasma and is excreted in urine. Methods for assessing total 8-iso-PGF2α typically require the alkaline hydrolysis of 8-iso-PGF2α esters from tissues, followed by length procedures involving extractions, phase separations and thin layer chromatography.
Cross Reactivity
| Compound | % Cross Reactivity |
| 8-iso-PGF2α | 100 |
| PGF1α | 4.6 |
| PGF2α | 1.85 |
| PGE1 | 0.19 |
| TXB2 | 0.023 |
| PGB1 | 0.02 |
| PGE3 | 0.012 |
| 6-keto-PGF1α | 0.008 |
| 13,14-dihydro-15-keto-PGF2α | 0.008 |
| 6,15-keto-13,14-dihydro-PGF1α | 0.005 |
| 8-iso-PGE1 | <0.001 |
| PGA2 | <0.001 |
| PGJ2 | <0.001 |
| 2-Arachidonoylglycerol | <0.001 |
| Anandamide | <0.001 |
Precision
Recovery
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
8-iso-PGF2α functions as a marker of oxidative stress within the organism. It participates in cell signaling affecting vascular tone and platelet aggregation. It does not form part of a larger protein complex by itself but acts through receptor-mediated mechanisms mainly interacting with thromboxane receptors to exert its effects. This interaction leads to vasoconstriction and plays roles in various cell signaling pathways.
Pathways
8-iso-PGF2α is involved in the oxidative stress response and the arachidonic acid metabolism pathways. It closely relates to the cyclooxygenase (COX) pathway intersecting with proteins such as COX-2 and modulating inflammatory responses. This interaction can influence the production of other prostanoids which further integrate into the inflammatory response pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Arteriosclerosis, thrombosis, and vascular biology 39:2303-2319 PubMed31510791
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of diabetes investigation 10:1189-1198 PubMed30825261
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com